Blinatumomab

ATC L01FX07 · 8 markets · 10 records

Blinatumomab 8 markets · 10 records Forms

AU 3 records · 3 strengths

0.0385 mginjectionBLINCYTO also in ES
38.5 mcg/ginjectionBLINCYTO blinatumomab (rch) 38.5 microgram powder for injection vial with Intravenous (IV) solution stabiliser unknown

Records without a stated strength · 1 BLINCYTO

GB 1 records · 1 strengths

Records without a stated strength · 1 Blincyto 38.5micrograms powder for concentrate and solution for solution for infusion vials

CA 1 records · 1 strengths

0.0385 mgpowderBLINCYTO

SG 1 records · 1 strengths

55 mcg/mLinjectionBLINCYTO POWDER FOR INFUSION 35 MCG/VIAL

ES 1 records · 1 strengths

0.0385 mginjectionBLINCYTO also in AU

TW 1 records · 1 strengths

Records without a stated strength · 1 BLINCYTO for Injection、百利妥注射劑

HK 1 records · 1 strengths

Records without a stated strength · 1 BLINCYTO POWDER FOR CONCENTRATE AND SOLUTION FOR SOLUTION FOR INFUSION 35MCG/VIAL

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 BLINCYTO

Side-by-side table

Strength / form / release	GB	CA	AU	SG	ES	TW	HK	EU
0.0385 mgRecorded as: 38.5 mcg、38.5 microgram injection	not recorded	not recorded	BLINCYTO	not recorded	BLINCYTO	not recorded	not recorded	not recorded
55 mcg/mL injection	not recorded	not recorded	not recorded	BLINCYTO POWDER FOR INFUSION 35 MCG/VIAL	not recorded	not recorded	not recorded	not recorded
38.5 mcg/g injection	not recorded	not recorded	BLINCYTO blinatumomab (rch) 38.5 microgram powder for injection vial with Intravenous (IV) solution stabiliser	not recorded	not recorded	not recorded	not recorded	not recorded
0.0385 mgRecorded as: 38.5 mcg powder	not recorded	BLINCYTO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed injection	Blincyto 38.5micrograms powder for concentrate and solution for solution for infusion vials	not recorded	not recorded	not recorded	not recorded	BLINCYTO for 百利妥注射劑	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	BLINCYTO	not recorded	not recorded	not recorded	BLINCYTO POWDER FOR CONCENTRATE AND SOLUTION FOR SOLUTION FOR INFUSION 35MCG/VIAL	BLINCYTO

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in SG and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en SG que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 SG 有记录（未在本表显示）。另有 1 個規格/劑型僅在 SG 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.